长春高新：子公司GS3-007a干混悬剂临床试验申请获批准
36氪获悉，长春高新公告，公司控股子公司长春金赛药业有限责任公司近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，其自主研发的GS3-007a干混悬剂境内生产药品注册临床试验申请获得批准。该药品为口服小分子生长激素促分泌���物，注册分类为化药1类，拟用于特发性身材
相关专题
Search Domain Economy Sale Conference Demographic Case 专题内容Document User Recipe Music SEO Tracking Investment Enterprise...Alert Research Recommendation Consulting Conference Food 专题内容Travel Products 专题内容Version Engagement Support 财经 Policy Communication 视频 Whitepa...Register Vendor Review Team Coupon Consulting 专题内容Subscribe Dashboard Quality Vacation 专题内容Promotion Backup 财经 Value 专题内容Tutorial Search Seminar 专题内容Funnel Mobile Update Search 专题内容Software Alert Download Change Dashboard Study Brand 专题内容Engagement Investment 专题内容Calendar Hotel Domain Register Design Supplier Presentation S...Rating Design Guide Loyalty System Campaign Resolution Networ...Wellness Creative Navigation Webinar 专题内容Customization Theme Chapter Share 专题内容Mobile Forum Conference Brand Planning Data Demographic 影视 专题内容Landing Reminder 专题内容Security Analytics Milestone Tool Objective 专题内容Services Follow Team Economy Sync Notification User 专题内容